Articles

Profile of onychomycosis in dermatology outpatient department at Sanglah General Hospital Denpasar, Bali-Indonesia periods 2016-2017

IGAA Dwi Karmila , Adeline Santoso

IGAA Dwi Karmila
Dept of Dermatology and Venereology, Udayana, Medical Faculty / Sanglah General Hospital Denpasar, Bali. Email: karmila@unud.ac.id

Adeline Santoso
Dept of Dermatology and Venereology, Udayana, Medical Faculty / Sanglah General Hospital Denpasar, Bali
Online First: May 11, 2018 | Cite this Article
Karmila, I., Santoso, A. 2018. Profile of onychomycosis in dermatology outpatient department at Sanglah General Hospital Denpasar, Bali-Indonesia periods 2016-2017. Bali Dermatology and Venereology Journal 1(1). DOI:10.15562/bdv.v1i1.5


Introduction: Onychomycosis is a fungal infection of the nails that causes discoloration, thickening, and separation from the nail bed. Onychomycosis is caused by various organisms, most often dermatophytes of the genus Trichophyton. Other organisms include Candida, which is more common in fingernail infections and patients with chronic mucocutaneous candidiasis. Nondermatophyte molds are a less common cause in the general population. This study aimed to identify sex, age, classification, fungal culture, treatment, and incident of secondary infection in onychomycosis at Dermatology Outpatient Department at Sanglah General Hospital Denpasar Periods January 2016 – December 2017.

Methods: Study design using descriptive retrospective model done by taking data from medical record in Dermatology Outpatient Department at Sanglah General Hospital Denpasar Periods 2016-2017.

Result: There were 268 patients in Dermatovenereology Outpatient Department at Sanglah General Hospital Denpasar, 29 (10,82%) of whom were diagnosed with onychomycosis in Periods 2016-2017. According to age group, the most cases occur in 26-65 year age groups. Females were more frequently affected than males. The most classification finding is distal and lateral subungual onychomycosis and the most commonly isolated fungi were yeasts from the Candida species. The most commonly given therapy is a combination therapy of systemic antifungal with topical. Fluconazole is the most common drug that uses orally and ciclopirox as topical agent.

Conclusions: Onychomycosis is one of the common fungal infection observed in patient attending dermatology outpatient department with the most classification finding is distal and lateral subungual onychomycosis. The most commonly isolated fungi were Candida sp.

Keywords: onychomycosis, fungal, nail

References

Thomas J, Jacobson GA, Narkowicz CK, Peterson GM, Burnet H, Sharpe C. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther. 2010;35(5):497–519.

Bramono K. Onikomikosis. 2013. Dermatomikosis Superfisial second edition. Medical Faculty Indonesia University : Jakarta.

Scher RK. Onychomycosis: a significant medical disorder. J Am Acad Dermatol. 1996;35(Part 2):S2-S5.

Surjushe A, Kamath R, Oberai C, et al. A clinical and mycological study of onychomycosis in HIV infection. Indian J Dermatol Venereol Leprol. 2007;73(6):397–401.

Alberhasky RC. Laboratory diagnosis of onychomycosis. Clin Podiatr Med Surg. 2004;21(4):565–578.

Hay RJ, Baran R. Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol. 2011;65(6):1219–1227.

Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol. 2000;43(4 suppl):S70–S80.

Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol. 2004;150(3):537–544.

Lopes JO, et all. A ten-year survey of onychomycosis in the Central Region of the Rio Grande do Sul, Brazil. 1999. Rev. Inst. Med. trop. S. Paulo vol.41 n.3 : São Paulo.

Zaias N, Glick B, Rebell G. Diagnosing and treating onychomycosis. J Fam Pract. 1996;42:513–518.

Pierard G. Onychomycosis and other superficial fungal infection of the foot in the elderly : A Pan-European Survey. 2001. Dermatology 2001;202:220–224 : Belgium.

Scher, R. K., et all. A placebo-controlled, randomized, double-blind trial of once-weekly fluconazole (150 mg, 300 mg, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. 2010. J. Am. Acad. Dermatol.

Elewski B E, Hay R J. Update on the management of onychomycosis: highlights of the third annual international summit on cutaneous antifungal therapy. Clin Infect Dis. 1996;23:305–313


No Supplementary Material available for this article.
Article Views      : 75
PDF Downloads : 29